Operating Lease, Right-of-Use Asset of LUMOS PHARMA, INC. from 01 Jan 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LUMOS PHARMA, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2024.
  • LUMOS PHARMA, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $187,000, a 30% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LUMOS PHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $187,000 -$81,000 -30% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $463,000 +$118,000 +34% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $534,000 +$114,000 +27% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $603,000 +$373,000 +162% 31 Dec 2023 10-Q 07 Nov 2024 2024 Q3
Q3 2023 $268,000 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $345,000 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $420,000 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $230,000 -$326,000 -59% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q4 2021 $556,000 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q4 2019 $735,000 -$6,765,000 -90% 31 Dec 2019 10-K 03 Mar 2020 2019 FY
Q4 2018 $7,500,000 01 Jan 2019 10-Q 06 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.